Critical Role of Iron in Epoetin Alfa Treatment of Chemotherapy-Associated Anemia

被引：3
|
作者：
Gross, Irwin [1 ,2 ]
Farmer, Shannon [3 ,4 ]
Hofmann, Axel [3 ,4 ,5 ]
Ozawa, Sherri [6 ]
Shander, Aryeh [6 ,7 ]
Aapro, Matti [8 ]
机构：
[1] Eastern Maine Med Ctr, Bangor, ME 04401 USA
[2] Accumen, San Diego, CA 92121 USA
[3] Univ Western Australia, Nedlands, WA 6009, Australia
[4] Curtin Univ, Perth, WA, Australia
[5] Univ Zurich, Zurich, Switzerland
[6] Englewood Hosp & Med Ctr, Englewood, NJ USA
[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[8] IMO Clin Genolier, Genolier, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 31期
关键词：
RECOMBINANT-HUMAN-ERYTHROPOIETIN; STIMULATING AGENTS; CANCER-PATIENTS; OPEN-LABEL; IV IRON; THROMBOSIS; MULTICENTER; DEFICIENCY; MORTALITY;
D O I：
10.1200/JCO.2016.67.7377
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3819 / +
页数：3
相关论文
共 50 条
  • [11] Synergy between epoetin alfa biosimilar and IV iron in chemotherapy-induced anemia
    Scotte, F.
    Laribi, K.
    Ray-Coquard, I.
    Kasdaghli, E.
    Gisselbrecht, C.
    Leutenegger, E.
    Spaeth, D.
    Albrand, H.
    ANNALS OF ONCOLOGY, 2015, 26 : 115 - 115
  • [12] Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness
    Voils, Stacy A.
    Harpe, Spencer H.
    Brophy, Gretchen M.
    PHARMACOTHERAPY, 2007, 27 (04): : 535 - 541
  • [13] Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies
    Case, Ashley S.
    Rocconi, Rodney P.
    Kilgore, Larry C.
    Barnes, Mack N.
    GYNECOLOGIC ONCOLOGY, 2006, 101 (03) : 499 - 502
  • [14] DARBEPOETIN ALFA VERSUS EPOETIN ALFA FOR TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA: A HEALTH ECONOMIC EVALUATION
    Finek, J.
    Holubec, L.
    Wiesnerova, A.
    Pav, Z.
    Dusek, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 344 - 344
  • [15] DARBEPOETIN ALFA VERSUS EPOETIN ALFA FOR TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA: A HEALTH ECONOMIC EVALUATION
    Finek, J.
    Holubec, L.
    Wiesnerova, A.
    Pav, Z.
    Dusek, L.
    TUMOR BIOLOGY, 2010, 31 : S102 - S103
  • [16] Every-three-week administration of darbepoetin alfa in women with chemotherapy-associated anemia
    Goram, Adrian L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (16) : 1522 - 1527
  • [17] Effect of modified front-load dosing of darbepoetin alfa for chemotherapy-associated anemia
    Goram, AL
    PHARMACOTHERAPY, 2004, 24 (10): : 1450 - 1450
  • [18] Clinical benefits and risks associated with darbepoetin alfa and epoetin alfa treatment in patients with lung cancer and chemotherapy-induced anemia.
    Tiotiu, Angelica
    Clerc-Urmes, Isabelle
    Chabot, Francois
    Martinet, Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [19] Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia
    Steensma, David P.
    Sloan, Jeff A.
    Dakhil, Shaker R.
    Dalton, Robert
    Kahanic, Stephen P.
    Prager, Diane J.
    Stella, Philip J.
    Rowland, Kendrith M., Jr.
    Novotny, Paul J.
    Loprinzi, Charles L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (01) : 97 - 105
  • [20] The Role of Intravenous Iron in the Treatment of Anemia Associated with Cancer and Chemotherapy
    Rodgers, George M.
    Gilreath, Jeffrey A.
    ACTA HAEMATOLOGICA, 2019, 142 (01) : 13 - 20
12345